293 related articles for article (PubMed ID: 10597731)
1. The challenge of locally advanced prostate cancer.
Pisters LL
Semin Oncol; 1999 Apr; 26(2):202-16. PubMed ID: 10597731
[TBL] [Abstract][Full Text] [Related]
2. A retrospective study of the treatment of locally advanced prostate cancer by six institutions in eastern and north-eastern Japan.
Hachiya T; Akakura K; Saito S; Shinohara N; Sato K; Harada M; Kato T; Okada K
BJU Int; 2005 Mar; 95(4):534-40. PubMed ID: 15705075
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of adjuvant hormonal therapy plus radiotherapy following radical prostatectomy for patients with pT3N0 or pT3N1 prostate cancer.
Miyake H; Sakai I; Harada K; Hara I; Eto H
Int J Urol; 2004 Jun; 11(6):397-401. PubMed ID: 15157209
[TBL] [Abstract][Full Text] [Related]
4. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer.
Zincke H; Lau W; Bergstralh E; Blute ML
J Urol; 2001 Dec; 166(6):2208-15. PubMed ID: 11696737
[TBL] [Abstract][Full Text] [Related]
5. Evolving treatment paradigms for locally advanced and metastatic prostate cancer.
Dorff TB; Quek ML; Daneshmand S; Pinski J
Expert Rev Anticancer Ther; 2006 Nov; 6(11):1639-51. PubMed ID: 17134367
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
[TBL] [Abstract][Full Text] [Related]
7. Radical prostatectomy for clinical T4 prostate cancer.
Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
[TBL] [Abstract][Full Text] [Related]
8. Novel treatment methods for localized prostate cancer: hypofractionated robotic radiation therapy and adjuvant chemotherapy.
Dawson NA; Collins SP
Expert Rev Anticancer Ther; 2009 Jul; 9(7):953-62. PubMed ID: 19589034
[TBL] [Abstract][Full Text] [Related]
9. [Radiotherapy combined with hormonal therapy as treatment method in patients with prostate cancer: still more questions than answers].
Milecki P
Przegl Lek; 2005; 62(12):1455-9. PubMed ID: 16786772
[TBL] [Abstract][Full Text] [Related]
10. [What is the best strategy of hormonal therapy in the treatment of locally advanced prostate cancer?].
Ehara H; Nakano M; Deguchi T
Hinyokika Kiyo; 2006 Jun; 52(6):473-7. PubMed ID: 16848361
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic options for localized carcinoma of the prostate: the role of external beam radiation therapy.
Khil MS; Kim JH
Henry Ford Hosp Med J; 1992; 40(1-2):103-7. PubMed ID: 1428958
[TBL] [Abstract][Full Text] [Related]
12. [Hormone therapy of locally advanced and metastatic prostate carcinoma].
Rübben H
Praxis (Bern 1994); 2001 Sep; 90(38):1641-4. PubMed ID: 11675917
[TBL] [Abstract][Full Text] [Related]
13. [Future prospects for primary hormone therapy in localized and locally advanced prostate cancer].
Akaza H; Hirao Y; Labrie F; Soloway MS
Hinyokika Kiyo; 2003 Dec; 49(12):771-7. PubMed ID: 14978964
[TBL] [Abstract][Full Text] [Related]
14. Technological advances in radiotherapy for the treatment of localised prostate cancer.
Mangar SA; Huddart RA; Parker CC; Dearnaley DP; Khoo VS; Horwich A
Eur J Cancer; 2005 Apr; 41(6):908-21. PubMed ID: 15808957
[TBL] [Abstract][Full Text] [Related]
15. [Treatment strategy for locally advanced prostate cancer].
Kurokawa K; Suzuki K; Yamanaka H
Gan To Kagaku Ryoho; 2003 Jan; 30(1):38-42. PubMed ID: 12557703
[TBL] [Abstract][Full Text] [Related]
16. Hormone therapy adjuvant to external beam radiotherapy for locally advanced prostate carcinoma: a complication-adjusted number-needed-to-treat analysis.
Jani AB; Kao J; Hellman S
Cancer; 2003 Dec; 98(11):2351-61. PubMed ID: 14635069
[TBL] [Abstract][Full Text] [Related]
17. Controversies in prostate cancer radiotherapy: consensus development.
Lukka H; Warde P; Pickles T; Morton G; Brundage M; Souhami L;
Can J Urol; 2001 Aug; 8(4):1314-22. PubMed ID: 11564274
[TBL] [Abstract][Full Text] [Related]
18. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor.
Grossfeld GD; Li YP; Lubeck DP; Broering JM; Mehta SS; Carroll PR
J Urol; 2002 Aug; 168(2):530-5. PubMed ID: 12131303
[TBL] [Abstract][Full Text] [Related]
19. Nomogram ranking as new objective evaluation method in various treatment strategies for patients with prostate cancer with various clinicopathologic backgrounds.
Yamamoto T; Ito K; Miyakubo M; Takechi H; Suzuki K; Akimoto T; Ishikawa H; Nakano T
Urology; 2008 Oct; 72(4):892-7. PubMed ID: 18372027
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant and salvage treatment options for patients with high-risk prostate cancer treated with radical prostatectomy.
Kibel AS; Nelson JB
Prostate Cancer Prostatic Dis; 2007; 10(2):119-26. PubMed ID: 17310261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
